biogen

Page 3 of 4

Biogen Sangamo Alzheimers gene therapy
Newsletters

Biogen is doubling down on Alzheimer’s with a massive gene therapy deal

By
February 28, 2020
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
Leadership

Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’

By
December 6, 2019
Biogen Alzheimers Drug Data
Newsletters

The Broader Implications of Biogen’s Divisive Alzheimer’s Drug

By
December 5, 2019
Biogen Stock Alzheimer's Aducanumab
Newsletters

Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet

By
December 2, 2019
Biogen Alzheimers Aducanumab
Newsletters

Let’s Talk About Biogen’s Stunning Alzheimer’s Drug Reversal: Brainstorm Health

By
October 23, 2019
Landlord To The Biotechs

Biogen Acquires Nightstar Therapeutics in $800 Million Gene Therapy Deal

By
March 4, 2019
Alzheimer's Biogen Eisai
Health

Why the Latest Alzheimer’s Drug Study Has So Many People Confused

By
July 30, 2018
BioGen Alzheimers
Health

Biogen’s Stock Is Soaring Because of Its Experimental Alzheimer’s Drug — But Some Are Urging Caution

By
July 6, 2018
COLOMBIA-YARUMAL-ALZHEIMER
Health

Alzheimer’s Cases Are Expected to Double By 2060 and We’re Not Ready for It

By
December 7, 2017
BioGen Alzheimers
Health

We’ve Had Terrible Luck Trying to Cure Alzheimer’s. But What If We Could Prevent It?

By
November 2, 2017
BioGen Alzheimers
Health

Could a New Immunotherapy Medical Approach Break the Alzheimer’s Drug Curse?

By
October 24, 2017
COLOMBIA-YARUMAL-ALZHEIMER
Health

Goldman Sachs Bet on Biogen’s Potential Landmark Alzheimer’s Drug Props Up Stock

By
August 16, 2017
Do You Really Want to Love Your Medicines?
Tech

Do You Really Want to Love Your Medicines?

By
June 19, 2017
Incoming Biogen CEO Michel Vounatsos
Health

Here’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Biotech

By
January 17, 2017
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership

This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again

By
October 12, 2016

Most Popular